IP Library Granted Patent US 10,961,175
Granted Patent B2
US 10,961,175 · App. 16/849,346 · Granted Mar 30, 2021

Process for preparing tapinarof

Inventors: Ian Paul Andrews (King of Prussia, PA); Nicholas Calandra (Cambridge, MA); Tyler Andrew Davis (Research Triangle Park, NC); Ravinder Reddy Sudini (King of Prussia, PA)
Assignee: DERMAVANT SCIENCES GMBH
C07C39/08C07C37/002C07C37/07C07C45/54C07C45/63C07C45/72C07C50/24C07C51/09C07C51/38C07C59/353C07C67/03C07C67/293C07C67/343C07C69/716A61K31/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,175
App. No.
16/849,346
Granted
Mar 30, 2021
Kind
B2
Abstract

The present invention provides processes for the preparation of 3, 5-Dihydroxy-4-isopropyl-trans-stilbene or a salt or solvate thereof and novel intermediates used therein. In some embodiments the 3, 5-Dihydroxy-4-isopropyl-trans-stilbene is prepared from (E)-2-chloro-2-isopropyl-5-styrylcyclohexane-1,3-dione. Also disclosed are crystal forms of 3, 5-Dihydroxy-4-isopropyl-trans-stilbene or a salt or solvate thereof and pharmaceutical compositions comprising same.

Claims (33)

1. A process for preparing a compound of Formula (I) or a salt or solvate thereof

comprising aromatizing a compound of Formula (II)

wherein X is Cl, Br, or I

to obtain the compound of Formula (I).

2. The process of claim 1 wherein X is Cl.

3. The process of claim 1 wherein the aromatizing comprises contacting the compound of Formula (II) with quaternary ammonium salt in a solvent.

4. The process of claim 3 , wherein the quaternary ammonium salt is tetraethylammonium chloride.

5. The process of claim 1 , further comprising halogenating a compound of Formula (III),

with a halogenating agent to obtain the compound of Formula (II).

6. The process of claim 5 wherein the halogenating agent is selected from the group consisting of 1,3-dichloro-5,5-dimethylhydantoin; N-chlorosuccinimide; and trichloroisocyanuric acid.

7. The process of claim 5 , wherein the halogenating is carried out in methanol and the halogenating agent is 1,3-dichloro-5,5-dimethylhydantoin.

8. The process of claim 5 , further comprising cyclizing a compound of Formula (IV),

wherein R is C 1-4 alkyl, to obtain the compound of Formula (III).

9. The process of claim 8 , wherein R is selected from the group consisting of methyl, ethyl, propyl, or butyl.

10. The process of claim 8 , wherein R is methyl or t-butyl.

11. The process of claim 8 , wherein the cyclizing comprises contacting the compound of Formula (IV) with potassium tert-butoxide in 2-methyltetrahydrofuran.

12. The process of claim 8 , further comprising esterifying a compound of Formula (V) or a salt thereof

to obtain the compound of Formula (IV).

13. The process of claim 12 , wherein the esterifying comprises heating the compound of Formula (V) or a salt thereof with aqueous hydrochloric acid in methanol.

14. The process of claim 12 , further comprising decarboxylating a compound of Formula (VI)

in the presence of a base, to obtain the compound of Formula (V) or a salt thereof.

15. The process of claim 14 , wherein the decarboxylating comprises heating the compound of Formula (VI) in the presence of triethylamine.

16. The process of claim 14 , further comprising hydrolyzing a compound of Formula (VII)

wherein each of R 1 and R 2 is independently C 1-4 alkyl; to obtain the compound of Formula (VI).

17. The process of claim 16 , wherein each of R 1 and R 2 is ethyl.

18. The process of claim 16 , wherein the hydrolyzing comprises treating the compound of Formula (VII) with sodium hydroxide in ethanol.

19. The process of claim 16 , further comprising adding a dialkyl malonic ester to a compound of Formula (VIII)

to obtain the compound of Formula (VII).

20. The process of claim 19 wherein the dialkyl malonic ester is di-tert-butylmalonate or diethyl malonate.

21. The process of claim 19 , wherein the adding comprises contacting the dialkyl malonic ester with the compound of Formula (VIII) in the presence of lithium bromide/triethylamine.

22. The process of claim 19 , further comprising condensing trans-cinnamaldehyde (IX)

with methyl isobutyl ketone to form the compound of Formula (VIII).

23. The process of claim 22 , wherein the condensing comprises treating the methyl isobutyl ketone with the trans-cinnamaldehyde in the presence of sodium hydroxide in methanol.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: US BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: DERMAVENT SCIENCES GMBH
Reel/Frame 069274/0101 →
SECURITY INTEREST Recorded May 19, 2021
From: DERMAVANT SCIENCES GMBH
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056399/0778 →
SECURITY INTEREST Recorded May 17, 2021
From: DERMAVANT SCIENCES GMBH
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056261/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: SUDINI, RAVINDER REDDY; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 052448/0101 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: GLAXO GROUP LIMITED; GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 052448/0110 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: ANDREWS, IAN PAUL; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 052448/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: CALANDRA, NICHOLAS; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 052448/0086 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: DAVIS, TYLER ANDREW; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 052448/0091 →
Cited By (1)
US 12,275,696